APA (7th ed.) Citation

Satyam, V. R., Li, P., Reich, J., Qazi, T., Noronha, A., Wasan, S. K., & Farraye, F. A. (2019). Su1932 – Safety of Recombinant Zoster Vaccine (Rzv-Shingrix) in Patients with Inflammatory Bowel Disease. Gastroenterology (New York, N.Y. 1943), 156(6), S-665-S-666. https://doi.org/10.1016/S0016-5085(19)38569-5

Chicago Style (17th ed.) Citation

Satyam, Venkata R., Pei-Hsuan Li, Jason Reich, Taha Qazi, Ansu Noronha, Sharmeel K. Wasan, and Francis A. Farraye. "Su1932 – Safety of Recombinant Zoster Vaccine (Rzv-Shingrix) in Patients with Inflammatory Bowel Disease." Gastroenterology (New York, N.Y. 1943) 156, no. 6 (2019): S-665-S-666. https://doi.org/10.1016/S0016-5085(19)38569-5.

MLA (9th ed.) Citation

Satyam, Venkata R., et al. "Su1932 – Safety of Recombinant Zoster Vaccine (Rzv-Shingrix) in Patients with Inflammatory Bowel Disease." Gastroenterology (New York, N.Y. 1943), vol. 156, no. 6, 2019, pp. S-665-S-666, https://doi.org/10.1016/S0016-5085(19)38569-5.